Research Output per year
Research Output per year
Organisation profile
About us
Luebeck Integrated Oncology Network (LION) is the association of all institutes and clinics at the University of Luebeck contributing to oncological research. As an essential part of the University Cancer Center Schleswig-Holstein (UCCSH) our focus lies on the investigation of malign tumors.
Click here to explore all LION and UCCSH related publications.
Click here to explore all LION and UCCSH related research projects.
Scientists at LION conduct research on:
- Biomarkers / Minimal Residual Disease
- Metastasis / Dissemination
- Inflammation and Cancer
- Immune Therapy & Oncological Immunology
- Rare Cancer Types
- Personalised Medicine
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Luebeck Integrated Oncology Network (LION) is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Profiles
-
Bruchhage Karl-Ludwig
- Clinic of Otorhinolaryngology
- Luebeck Integrated Oncology Network (LION) - Group Leading Senior Scientist
Person: W3 Professor
-
Gebauer Niklas
- Luebeck Integrated Oncology Network (LION) - Group Leading Senior Scientist
Person: Lecturer
-
Gemoll Timo
- Luebeck Integrated Oncology Network (LION) - Group Leading Senior Scientist
- Clinic of Surgery - Group Leading Senior Scientist
Person: W2 Professor
Research output
-
Anti-inflammatory response to 1,8-Cineol and associated microbial communities in Otitis media patients
Leichtle, A., Lupatsii, M., Graspeuntner, S., Jeschke, S., Penxová, Z., Kurabi, A., Ryan, A. F., Rupp, J., Pries, R. & Bruchhage, K. L., 12.2024, In: Scientific Reports. 14, 1, 16362.Research output: Journal Articles › Journal articles › Research › peer-review
-
Comparison of 6 cycles of isatuximab with lenalidomide, bortezomib and dexamethasone (I-VRd) versus 3 cycles of I-VRd followed by one cycle of high-dose melphalan in newly diagnosed low-risk multiple myeloma. Protocol for a multicenter, prospective, randomized, phase II clinical trial (ELIAS-Trial)
Leitner, T., Shumilov, E., Schwitlick, C., Koch, R., Hamm, F., Högner, M., Bassermann, F., Weisel, K., Einsele, H., Kortüm, M., Rasche, L., Görner, M., Wegehenkel, K., Knop, S., Krönke, J., Nogai, A., König, I. R., Vens, M., Horn, K. & von Bubnoff, N. & 1 others, , 2024, In: Frontiers in Hematology. 3, 1436845.Research output: Journal Articles › Journal articles › Research › peer-review
-
Effectiveness of high efficiency particulate (HEPA) air condition combined with the antifungal prophylaxis on incidence, morbidity and mortality of invasive fungal infections in patients with acute myeloid leukemia: a retrospective single-center study
Preyer, L., Vettorazzi, E., Fiedler, W., Rohde, H., Stemler, J., Gönner, S., Bokemeyer, C., Khandanpour, C., Wortmann, F. & Kebenko, M., 2024, In: Frontiers in Oncology. 14, p. 1429221Research output: Journal Articles › Journal articles › Research › peer-review
-
Perioperative hydrocortisone treatment in pancreatoduodenectomy – randomized double-blinded placebo-controlled interventional trial (PD-HYDRA)
Wellner, U. (Principal Investigator (PI)) & Keck, T. (Co-PI)
01.01.23 → 31.12.26
Project: DFG Projects › DFG Clinical Trials
-
Outlive-CRC - Liquid Biopsy and Nutrition in CRC Prevention
Derer-Petersen, S. (Speaker, Coordinator), Burziwoda, D. (Principal Investigator (PI)), Katalinic, A. (Principal Investigator (PI)), Oberländer, M. (Principal Investigator (PI)), Deck, R. (Principal Investigator (PI)), Sültmann, H. (Principal Investigator (PI)), von Bubnoff, N. (Principal Investigator (PI)), Gemoll, T. (Principal Investigator (PI)), Busch, H. S. (Principal Investigator (PI)), Jülg, P. (Principal Investigator (PI)), Hutzenlaub, T. (Principal Investigator (PI)), Sina, C. (Principal Investigator (PI)), Schröder, T. (Principal Investigator (PI)) & Lill, C. (Project Staff)
01.03.22 → 31.12.25
Project: Projects with Federal Funding › Federal Funding: BMBF (Education and Research)
-
Pancreatogastrostomy versus pancreatojejunostomy for RECOnstruction after partial PANCreatoduodenectomy - A randomized controlled trial (RECOPANC)
Keck, T. (Principal Investigator (PI))
01.01.11 → 31.12.15
Project: DFG Projects › DFG Clinical Trials